Platinum based chemotherapy: clinical trials recruiting now
7
Recruiting trials
9
Conditions studied
19
US states with sites
17
Countries
Phase breakdown
Phase 1 1
Phase 2 5
Phase 3 1
Not applicable 1
Conditions being studied
Recruiting trials involving Platinum based chemotherapy
- A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC
- A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
- A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
- An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
- Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Common questions
How many recruiting trials involve Platinum based chemotherapy?
7 recruiting trials across 9 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.